86 related articles for article (PubMed ID: 16442532)
1. Interaction of metallothionein with tumor suppressor p53 protein.
Ostrakhovitch EA; Olsson PE; Jiang S; Cherian MG
FEBS Lett; 2006 Feb; 580(5):1235-8. PubMed ID: 16442532
[TBL] [Abstract][Full Text] [Related]
2. P53 mediated regulation of metallothionein transcription in breast cancer cells.
Ostrakhovitch EA; Olsson PE; von Hofsten J; Cherian MG
J Cell Biochem; 2007 Dec; 102(6):1571-83. PubMed ID: 17477370
[TBL] [Abstract][Full Text] [Related]
3. Restoring wtp53 activity in HIPK2 depleted MCF7 cells by modulating metallothionein and zinc.
Puca R; Nardinocchi L; Bossi G; Sacchi A; Rechavi G; Givol D; D'Orazi G
Exp Cell Res; 2009 Jan; 315(1):67-75. PubMed ID: 18996371
[TBL] [Abstract][Full Text] [Related]
4. Vanadium induces apoptosis and modulates the expressions of metallothionein, Ki-67 nuclear antigen, and p53 during 2-acetylaminofluorene-induced rat liver preneoplasia.
Chakraborty T; Samanta S; Ghosh B; Thirumoorthy N; Chatterjee M
J Cell Biochem; 2005 Mar; 94(4):744-62. PubMed ID: 15565650
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II-induced p53-dependent cardiac apoptotic cell death: its prevention by metallothionein.
Liu Q; Wang G; Zhou G; Tan Y; Wang X; Wei W; Liu L; Xue W; Feng W; Cai L
Toxicol Lett; 2009 Dec; 191(2-3):314-20. PubMed ID: 19808082
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical localization of metallothionein and p53 protein in pancreatic serous cystadenomas.
Sliwińska-Mossoń M; Milnerowicz H; Rabczyński J; Milnerowicz S
Arch Immunol Ther Exp (Warsz); 2009; 57(4):295-301. PubMed ID: 19578815
[TBL] [Abstract][Full Text] [Related]
7. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
[TBL] [Abstract][Full Text] [Related]
8. Metallothionein and apoptosis during differentiation of myoblasts to myotubes: protection against free radical toxicity.
Apostolova MD; Ivanova IA; Cherian MG
Toxicol Appl Pharmacol; 1999 Sep; 159(3):175-84. PubMed ID: 10486304
[TBL] [Abstract][Full Text] [Related]
9. Basal and copper-induced expression of metallothionein isoform 1,2 and 3 genes in epithelial cancer cells: The role of tumor suppressor p53.
Ostrakhovitch EA; Song YP; Cherian MG
J Trace Elem Med Biol; 2016 May; 35():18-29. PubMed ID: 27049123
[TBL] [Abstract][Full Text] [Related]
10. Missense mutations of BRCA1 gene affect the binding with p53 both in vitro and in vivo.
Quaresima B; Faniello MC; Baudi F; Crugliano T; Di Sanzo M; Cuda G; Costanzo F; Venuta S
Oncol Rep; 2006 Oct; 16(4):811-5. PubMed ID: 16969499
[TBL] [Abstract][Full Text] [Related]
11. Expression of metallothionein and p53 antigens are correlated in oral squamous cell carcinoma.
Cardoso SV; Silveira-Júnior JB; De Carvalho Machado V; De-Paula AM; Loyola AM; De Aguiar MC
Anticancer Res; 2009 Apr; 29(4):1189-93. PubMed ID: 19414363
[TBL] [Abstract][Full Text] [Related]
12. A novel domain of BRCA1 interacts with p53 in breast cancer cells.
Buck M
Cancer Lett; 2008 Sep; 268(1):137-45. PubMed ID: 18501503
[TBL] [Abstract][Full Text] [Related]
13. Adaptor protein LAPF recruits phosphorylated p53 to lysosomes and triggers lysosomal destabilization in apoptosis.
Li N; Zheng Y; Chen W; Wang C; Liu X; He W; Xu H; Cao X
Cancer Res; 2007 Dec; 67(23):11176-85. PubMed ID: 18056442
[TBL] [Abstract][Full Text] [Related]
14. Studies of interaction of tumor suppressor p53 with apo-MT using surface plasmon resonance.
Xia N; Liu L; Yi X; Wang J
Anal Bioanal Chem; 2009 Dec; 395(8):2569-75. PubMed ID: 19865814
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer amplified sequence 2, a novel negative regulator of the p53 tumor suppressor.
Kuo PC; Tsao YP; Chang HW; Chen PH; Huang CW; Lin ST; Weng YT; Tsai TC; Shieh SY; Chen SL
Cancer Res; 2009 Dec; 69(23):8877-85. PubMed ID: 19903847
[TBL] [Abstract][Full Text] [Related]
16. Repression of SHP-1 expression by p53 leads to trkA tyrosine phosphorylation and suppression of breast cancer cell proliferation.
Montano X
Oncogene; 2009 Oct; 28(43):3787-800. PubMed ID: 19749791
[TBL] [Abstract][Full Text] [Related]
17. Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression.
Bon G; Di Carlo SE; Folgiero V; Avetrani P; Lazzari C; D'Orazi G; Brizzi MF; Sacchi A; Soddu S; Blandino G; Mottolese M; Falcioni R
Cancer Res; 2009 Jul; 69(14):5978-86. PubMed ID: 19567674
[TBL] [Abstract][Full Text] [Related]
18. Over-expression of metallothionein predicts chemoresistance in breast cancer.
Yap X; Tan HY; Huang J; Lai Y; Yip GW; Tan PH; Bay BH
J Pathol; 2009 Mar; 217(4):563-70. PubMed ID: 19116991
[TBL] [Abstract][Full Text] [Related]
19. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.
Shankar S; Srivastava RK
Int J Oncol; 2007 Apr; 30(4):905-18. PubMed ID: 17332930
[TBL] [Abstract][Full Text] [Related]
20. Novel triterpenoid 25-hydroxy-3-oxoolean-12-en-28-oic acid induces growth arrest and apoptosis in breast cancer cells.
Rabi T; Wang L; Banerjee S
Breast Cancer Res Treat; 2007 Jan; 101(1):27-36. PubMed ID: 17028990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
